List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 4739 studies with search of: Immune globulin OR Gamimune N, Gammagard S/D, Gamunex[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)
Condition: Anthrax
Interventions: Biological: Anthrax Immune Globulin Intravenous (AIGIV);   Biological: Gamunex
2 Completed Specific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous Immunoglobulin
Conditions: Common Variable Immunodeficiency;   Agammaglobulinemia
Intervention: Biological: gammaglobulin
3 Active, not recruiting Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) for Previously Untreated, Advanced-stage, Low Grade Non-Hodgkin's Lymphoma
Condition: Lymphoma, Non-Hodgkin
Intervention: Biological: Tositumomab and Iodine I 131 Tositumomab (Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody)
4 Recruiting Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Biological: therapeutic immune globulin;   Other: laboratory biomarker analysis
5 Completed Yellow Fever Virus Vaccine and Immune Globulin Study
Conditions: Viremia;   Immune Response to Yellow Fever Virus Vaccination
Intervention: Biological: YF-VAX and Gama STAN S/D
6 Completed Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver Transplantation
Condition: Hepatitis B, Chronic
Intervention: Drug: Specific intravenous anti-hepatitis B immunoglobulin
7 Active, not recruiting Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation
Conditions: Hepatitis C Virus;   Liver Transplantation
Interventions: Biological: Hepatitis C Immune Globulin Intravenous (Human) 5%;   Biological: observational control
8 Recruiting Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent Miscarriage
Condition: Secondary Recurrent Miscarriage
Interventions: Drug: Intravenous immunoglobulin;   Drug: Human albumin
9 Completed Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin
Condition: Anthrax
Intervention: Drug: Anthrax Immune Globulin
10 Completed Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy
Condition: Hereditary Inclusion Body Myopathy
Intervention: Drug: Immune Globulin
11 Active, not recruiting Study of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received Rituximab
Condition: Non-Hodgkin's Lymphoma
Intervention: Biological: Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab)
12 Active, not recruiting Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease
Conditions: Hyperbilirubinemia;   Erythroblastosis, Fetal
Interventions: Drug: Intravenous Immunoglobulin;   Drug: Normal saline solution
13 Suspended Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Biological: anti-CD45 monoclonal antibody AHN-12;   Radiation: yttrium Y 90 anti-CD45 monoclonal antibody AHN-12
14 Completed Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Interventions: Drug: Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified;   Drug: Albumin (Human) 25%, USP
15 Recruiting A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease
Condition: Alzheimer´s Disease
Interventions: Drug: Immune Globulin Intravenous (Human), 10% (IGIV, 10%);   Other: Placebo solution
16 Completed Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP
Condition: Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified
17 Completed Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease
Condition: Clostridium Infections
Interventions: Biological: GS-CDA1;   Biological: MDX-1388;   Biological: normal saline
18 Completed Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified;   Drug: Albumin (Human) 25%, USP
19 Terminated Intravenous Immunoglobulin After Relapse in Vasculitis
Conditions: ANCA + Vasculitides Relapsing Either Under Corticosteroid;   and Immunosuppressant Therapies or After One Year;   Post Treatment.
Intervention: Drug: Intravenous immunoglobulins (human immunoglobulins G)
20 Active, not recruiting Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement
Condition: Lymphoma, Non-Hodgkin
Intervention: Biological: dose-escalation

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services